The EndBrainCancer Initiative (EBCI) invites you to the live
"A Promising New Targeted Radiation Therapy for Leptomeningeal Metastases in Breast Cancer, Lung Cancer, and Other Malignancies: An Introduction"
Andrew Brenner, M.D. Ph.D. - the speaker
Professor of Medicine, Neurology, and Neurosurgery at The University of Texas Health Science Center at San Antonio and principal investigator of the ReSPECT-LM clinical trial.
This event was held on Sunday, October 9th, 2022 as part of the Musella Foundation Webinar Series. A recording of the event is available below.